alanine has been researched along with Adenoma, Basal Cell in 12 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested these hypotheses among participants in the Aspirin/Folate Polyp Prevention Study who were randomly assigned to placebo or to aspirin treatment (81 or 325 mg daily) and followed for 3 years for the occurrence of new adenomas." | 7.73 | Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. ( Ahnen, DJ; Baron, JA; Barry, EL; Bhat, S; Burke, CA; Grau, MV; Haile, RW; O'Brien, TG; Sandler, RS, 2006) |
| "In this prospective, randomized, multicenter, open-label, and comparative study, patients who had undergone ESD for EGC or gastric adenoma were randomized into groups receiving either rabeprazole monotherapy (10 mg/day, n=64) or a combination of rabeprazole plus rebamipide (300 mg/day, n=66)." | 5.22 | Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy. ( Akahoshi, K; Akiho, H; Aso, A; Harada, N; Iboshi, Y; Ihara, E; Iwasa, T; Nakamura, K; Nakamura, N; Ochiai, T; Ogino, H; Takayanagi, R, 2016) |
| "We tested these hypotheses among participants in the Aspirin/Folate Polyp Prevention Study who were randomly assigned to placebo or to aspirin treatment (81 or 325 mg daily) and followed for 3 years for the occurrence of new adenomas." | 3.73 | Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention. ( Ahnen, DJ; Baron, JA; Barry, EL; Bhat, S; Burke, CA; Grau, MV; Haile, RW; O'Brien, TG; Sandler, RS, 2006) |
| "Although colorectal cancer (CRC) is considered one of the most preventable cancers, no non-invasive, accurate diagnostic tool to screen CRC exists." | 1.51 | Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer. ( Kim, ER; Kim, JJ; Kim, YH; Kwon, HN; Nam, H; Park, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, ER | 1 |
| Kwon, HN | 1 |
| Nam, H | 1 |
| Kim, JJ | 1 |
| Park, S | 1 |
| Kim, YH | 1 |
| Xiong, J | 1 |
| Lai, S | 1 |
| Zhang, P | 1 |
| Li, Q | 1 |
| Wei, Y | 1 |
| Yang, Y | 1 |
| Wang, T | 1 |
| Liu, L | 1 |
| Ma, X | 1 |
| Chen, D | 1 |
| Nakamura, K | 1 |
| Ihara, E | 1 |
| Akiho, H | 1 |
| Akahoshi, K | 1 |
| Harada, N | 1 |
| Ochiai, T | 1 |
| Nakamura, N | 1 |
| Ogino, H | 1 |
| Iwasa, T | 1 |
| Aso, A | 1 |
| Iboshi, Y | 1 |
| Takayanagi, R | 1 |
| Shin, WG | 1 |
| Kim, SJ | 1 |
| Choi, MH | 1 |
| Kim, KO | 1 |
| Jang, HJ | 1 |
| Park, CH | 1 |
| Baek, IH | 1 |
| Kim, KH | 1 |
| Baik, GH | 1 |
| Kae, SH | 1 |
| Kim, JH | 1 |
| Kim, HY | 1 |
| Levine, AJ | 1 |
| Elkhouly, E | 1 |
| Diep, AT | 1 |
| Lee, ER | 1 |
| Frankl, H | 1 |
| Haile, RW | 2 |
| Gong, Z | 1 |
| Xie, D | 1 |
| Deng, Z | 1 |
| Bostick, RM | 1 |
| Muga, SJ | 1 |
| Hurley, TG | 1 |
| Hebert, JR | 1 |
| Barry, EL | 1 |
| Baron, JA | 1 |
| Bhat, S | 1 |
| Grau, MV | 1 |
| Burke, CA | 1 |
| Sandler, RS | 1 |
| Ahnen, DJ | 1 |
| O'Brien, TG | 1 |
| Niwa, Y | 1 |
| Nakamura, M | 1 |
| Omiya, N | 1 |
| Itoh, A | 1 |
| Hirooka, Y | 1 |
| Goto, H | 1 |
| Paschke, R | 1 |
| Tonacchera, M | 1 |
| Van Sande, J | 1 |
| Parma, J | 1 |
| Vassart, G | 1 |
| Pei, L | 1 |
| Melmed, S | 1 |
| Scheithauer, B | 1 |
| Kovacs, K | 1 |
| Prager, D | 1 |
| Doliński, A | 1 |
| Mahlstedt, J | 1 |
| Joseph, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? : Multicenter, Randomized, and Prospective Study[NCT01167101] | 290 participants (Actual) | Interventional | 2009-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alanine and Adenoma, Basal Cell
| Article | Year |
|---|---|
Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
Topics: Adenoma; Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy, | 2014 |
3 trials available for alanine and Adenoma, Basal Cell
| Article | Year |
|---|---|
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopic Mucosal Resection; | 2016 |
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Topics: Adenoma; Aged; Alanine; Anti-Ulcer Agents; Carcinoma; Chi-Square Distribution; Confidence Intervals; | 2012 |
[Decompensation of autonomous thyroid adenoma after long-term iodine intake (author's transl)].
Topics: Adenoma; Adult; Alanine; Contrast Media; Female; Humans; Iodobenzoates; Long-Term Care; Middle Aged; | 1973 |
8 other studies available for alanine and Adenoma, Basal Cell
| Article | Year |
|---|---|
Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Alanine; Aminoisobutyric Acids; Biomarkers, Tumor; Colorect | 2019 |
The MnSOD A16V mitochondrial targeting sequence polymorphism is not associated with increased risk of distal colorectal adenomas: data from a sigmoidoscopy-based case control study.
Topics: Adenoma; Aged; Alanine; alpha-Tocopherol; Antioxidants; Case-Control Studies; Codon; Colorectal Neop | 2002 |
The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.
Topics: Adenoma; Adult; Aged; Alanine; Colorectal Neoplasms; Female; Heterozygote; Humans; Male; Middle Aged | 2005 |
Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Topics: Adenoma; Adenomatous Polyposis Coli; Aged; Alanine; Anticarcinogenic Agents; Aspirin; Colorectal Neo | 2006 |
Ileal cancer and erosions in the small intestine revealed by capsule endoscopy.
Topics: Adenocarcinoma; Adenoma; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Capsule Endoscopy; Colonic N | 2007 |
Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.
Topics: Adenoma; Alanine; Amino Acid Sequence; Base Sequence; Cell Line; Codon; Cyclic AMP; Gene Expression; | 1994 |
H-ras mutations in human pituitary carcinoma metastases.
Topics: Adenoma; Alanine; Arginine; Base Sequence; DNA, Neoplasm; Exons; Genes, p53; Genes, ras; Glycine; Hu | 1994 |
Role of alanine in the production of endogenous glucose in patients with intracranial pathology.
Topics: Adenoma; Alanine; Blood Glucose; Brain Damage, Chronic; Brain Death; Brain Diseases; Brain Neoplasms | 1979 |